Mark T. Giles

Insider Reports History

Entity
Individual
Location
2020 Avon Court, Suite 4, Charlottesville, VA
Signature
/s/ William R. Elder, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark T. Giles:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Diffusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 83.3K Jul 1, 2021 Direct

Insider Reports Filed by Mark T. Giles

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DFFN Diffusion Pharmaceuticals Inc. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director